Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(11)
- IκB/IKK(64)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(139)
- NF-κB(233)
- Interleukin Related(167)
- 15-lipoxygenase(2)
- Others(62)
- Aryl Hydrocarbon Receptor(35)
- CD73(14)
- Complement System(57)
- Galectin(12)
- IFNAR(25)
- NO Synthase(73)
- NOD-like Receptor (NLR)(50)
- STING(104)
- Reactive Oxygen Species(453)
- Apoptosis(777)
- FKBP(20)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(53)
- Adaptive Immunity(209)
- Allergy(122)
- Arthritis(34)
- Autoimmunity(179)
- Gastric Disease(92)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(556)
- Pulmonary Diseases(105)
- Reactive Nitrogen Species(50)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(49)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
- Cat.No. 产品名称 Information
-
GC37951
YKL-06-061
YKL 06-061 is a potent and selective salt-inducible kinase (SIK) inhibitor with IC50 of 6.56 nM, 1.77 nM and 20.5 nM for SIK1, SIK2 and SIK3, respectively.
-
GC37850
Tyrphostin A1
(4-甲氧基苄烯)丙二腈,Tyrphostin 1; AG9
Tyrphostin A1(AG9)能抑制巨噬细胞培养中CD40L刺激的IL-12产生和抗原诱导的Th1细胞生成。
-
GC37809
Tocilizumab
托珠单抗; Anti-Human IL6R, Humanized Antibody
Tocilizumab 作为一种人源化单克隆抗体,可以靶向 IL-6 受体的膜结合和可溶形式。
-
GC37748
TBK1/IKKε-IN-5
TBK1/IKKε-IN-1 (compound 1) is a dual inhibitor of TANK-binding kinase 1 (TBK1) and IκB kinase-ε (IKKε/IKK-i) with IC50 of 1.0 nM and 5.6 nM for TBK1 and IKKε, respectively. TBK1/IKKε inhibition enhances response to PD-1 blockade, which effectively predicts tumor response in vivo.
-
GC37747
TBK1/IKKε-IN-1
TBK1/IKKε-IN-1 是一种双重 TBK1 和 IKKε 抑制剂,IC50s 值 <100 nM。详细信息请参考专利文献 US20160376283 A1 中 Example 60 中的化合物 274。
-
GC37705
Suramin
苏拉明
A polysulfonated naphthylurea with antiviral, antiparasitic, and anticancer activities
-
GC37700
Succinyl phosphonate trisodium salt
琥珀酰膦酸盐
Succinyl phosphonate trisodium salt (SP) 琥珀酰膦酸三钠盐是 α-酮戊二酸脱氢酶 (KGDHC ) 抑制剂,可有效抑制肌肉,细菌,脑和人成纤维细胞中的 KGDHC。Succinyl phosphonate trisodium salt (SP) 抑制 2-氧代戊二酸脱氢酶 (OGDH),以细胞特异性代谢依赖性方式损害癌细胞的活力。Succinyl phosphonate trisodium salt (SP) 抑制谷氨酸诱导的谷氨酸刺激的海马神经元中的 ROS 产生。
-
GC37693
STING agonist-4
CS-0087594, Diamidobenzimidazole STING Agonist-2, diABZI-4, HY-123943, STING Agonist-4, STING Agonist diABZI Compound 2
A STING agonist
-
GC37692
STING agonist-3
CS-0029879, Diamidobenzimidazole STING Agonist, diABZI-3, EX-A3217, HY-103665, STING Agonist-3
A STING agonist
-
GC37686
Stachydrine
水苏碱
A pyrrolidine betaine with anticancer and cardioprotective effects
-
GC37661
Sodium formononetin-3'-sulfonate
芒柄花黄素-3'-磺酸钠,Sul-F
Sodium formononetin-3'-sulfonate (Sul-F)是formononetin的水溶性衍生物。
-
GC37603
SC144 hydrochloride
A gp130 inhibitor
-
GC37531
Riboflavin Tetrabutyrate
核黄素四丁酸酯;四丁酸核糖黄素酯
Riboflavin tetrabutyrate is a lipophilic flavin derivative with antioxidative and lipid peroxide-removing activity.
-
GC37036
PTD-p65-P1 Peptide
PTD-p65-P1 Peptide 是一种核转录因子 NF-kappaB 抑制剂,由一个 antennapedia 衍生的膜转运肽序列 (PTD) 连接 p65-P1 构成, 选择性地抑制由各种刺激诱导的 NF-kappaB 活性。
-
GC36914
Piceatannol 3'-O-glucoside
白皮杉醇 3'-O-葡萄糖苷; Quzhaqigan
Piceatannol 3'-O-glucoside 是 Rhubarb 的一种活性成分,通过抑制精氨酸酶 (Arginase) 活性激活内皮细胞一氧化氮合酶 (NO synthase),抑制 Arginase I 和 Arginase II,IC50 值分别为 11.22 μM 和 11.06 μM。
-
GC36794
Okanin
奥卡宁
Okanin 是 Coreopsis tinctoria 的有效成分。Okanin 通过抑制 TLR4/NF-κB 信号通路减弱 LPS 诱导的小胶质细胞活化。
-
GC36773
Nrf2-IN-1
Nrf2-IN-1是nuclear factor-erythroid 2-related factor 2 (Nrf2)的抑制剂,用于急性髓系白血病(AML)的研究。
-
GC36757
NO-prednisolone
NO-泼尼松龙; NCX-1015
NO-prednisolone 是释放一氧化氮 (NO) 的 Prednisolone 衍生物。NO-prednisolone 有效刺激体内 IL-10 产生。
-
GC36696
Naringin Dihydrochalcone
柚皮苷二氢查尔酮; Naringin DC
A flavonoid with antioxidant activity
-
GC36649
mPGES1-IN-3
mPGES1-IN-3 (Compound 17d) 是一种有效的选择性微粒体前列腺素 E2 合成酶-1 (mPGES-1) 抑制剂,抑制 mPGES-1 酶,IC50 为 8 nM,抑制 A549 细胞,IC50 为 16.24 nM。
-
GC36588
MethADP sodium salt
MethADP (sodium salt) 是一个特异性的 CD73 抑制剂。
-
GC36587
MethADP
腺苷5'-(Α,Β-亚甲基)二磷酸,Adenosine 5'-(α,β-methylene)diphosphate
MethADP 是一个特异性的 CD73 抑制剂。
-
GC36578
MD2-TLR4-IN-1
MD2-TLR4-IN-1 (Compound 22m) is a potent inhibitor of myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4). MD2-TLR4-IN-1 (compound 22m) inhibits lipopolysaccharide (LPS)-induced expression of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in macrophages with IC50 of 0.89 μM and 0.53 μM, respectively.
-
GC36492
Luciferase
荧光素酶
Luciferase是一种能够催化生物发光反应的酶。
-
GC36472
LNP023
LNP023
LNP023 (LNP023) 是一流的、具有口服生物利用度的、高效和高选择性的因子 B 抑制剂,IC50 值为 10 nM。
-
GC36471
L-NIL
A selective iNOS inhibitor
-
GC36463
Limaprost
利马前列素; 17α,20-dimethyl-δ2-PGE1; ONO1206; OP1206
A stable, potent analog of PGE1
-
GC36456
Licoricidin
甘草西定
Licoricidin (LCD) 从甘草 Glycyrrhiza uralensis Fisch 中分离,具有抗癌活性。Licoricidin (LCD) 通过诱导周期停滞,诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),是一种对抗结直肠癌的潜在化学预防或化学治疗剂。Licoricidin (LCD) 通过抑制肿瘤血管生成和淋巴管生成以及肿瘤组织局部微环境的变化抑制肺转移。Licoricidin (LCD) 通过体外和体内 Akt 和 NF-κB 途径的失活,增强吉西他滨诱导的骨肉瘤 (OS) 细胞的细胞毒性。Licoricidin (LCD) 通过 ROS 清除阻断 UVA 诱导的光老化,限制 MMP-1 的活性,被认为是新的局部应用的抗衰老制剂中的活性成分。
-
GC36446
Licochalcone D
甘草查尔酮 D
Licochalcone D (Lico D, LCD, LD), a flavonoid isolated from a Chinese medicinal plant Glycyrrhiza inflata, has antioxidant, anti-inflammatory and anti-cancer properties. Licochalcone D inhibit phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone D inhibits JAK2, EGFR and Met (c-Met) activities and induces ROS-dependent apoptosis. Licochalcone D also induces caspases activation and poly (ADP-ribose) polymerase (PARP) cleavage.
-
GC36443
Levomefolic acid
5-甲基四氢叶酸; 5-MTHF
Levomefolic acid是一种具有口服活性且可通过血脑屏障的叶酸生物活性形式。
-
GC36390
Keap1-Nrf2-IN-1
Keap1–Nrf2 IN-1 (compound35) 是一种 Keap1- nrf2 蛋白-蛋白相互作用抑制剂,对 Keap1 蛋白作用的 IC50 值为 43 nM。Keap1–Nrf2 IN-1 (compound35) 能激活 Nrf2 调节的细胞保护反应,并在细胞和体内模型中对乙酰氨基酚诱导的肝损伤产生拮抗作用。
-
GC36301
IKKγ NBD Inhibitory Peptide
IKKγ NBD Inhibitory Peptide是 NEMO 结合域的多肽,对应着 NEMO 氨基端α螺旋区,可以阻断 TNFα 诱导的 NF-kB 激活。
-
GC36296
IFN-α Receptor Recognition Peptide 1
IRRP1
IFN-α Receptor Recognition Peptide 1 是 IFN-α 的一个多肽序列,为 IFN-α 受体识别肽。
-
GC36262
Huangjiangsu A
黄姜A
Huangjiangsu A 是从 D. villosa 中分离的原三角藻皂苷元。Huangjiangsu A 抗 H2O2-诱导的细胞毒性和 ROS 生成,具有肝保护作用。
-
GC36254
HPGDS inhibitor 2
HPGDS inhibitor 2 是一种高效选择性的造血前列腺素 D 合成酶 (H-PGDS) 抑制剂,IC50 值为 9.9 nM。
-
GC36176
Gomisin D
戈米辛 D
A lignan with diverse biological activities
-
GC36106
Gamma-glutamylcysteine (TFA)
γ-Glutamylcysteine TFA
Gamma-glutamylcysteine (TFA) ((γ-glutamylcysteine (TFA))是谷胱甘肽 (GSH) 合成的中间体,一种作为抗氧化酶谷胱甘肽过氧化物酶 (GPx) 的必需辅助因子的二肽。 Gamma-glutamylcysteine (TFA) 上调抗炎细胞因子 IL-10 的水平,降低促炎细胞因子 (TNF-α,IL-6 和 IL-1β) 的水平,并减弱在寡聚 Aβ40 处理的星形胶质细胞中金属蛋白酶活性的变化。
-
GC36043
FICZ
6-甲酰基吲哚并[3,2-B]咔唑,6-Formylindolo[3,2-b]carbazole
FICZ(甲酰吲哚 咔唑)作为芳基烃受体 (AhR) 的内源性配体,可以发挥多效性作用,包括防止炎症、纤维化和氧化应激。
-
GC36035
FD-IN-1
FD-IN-1 (Compound 12) 是一种补体因子 D (FD) 抑制剂,IC50 为 12 nM。补体因子 D 是一种高特异性的 S1 丝氨酸蛋白酶,在先天免疫系统的替代补体途径中起着重要作用。FD-IN-1 还抑制因子 XIa (FXIa) 和类胰蛋白酶 β2,IC50 分别为 7.7 和 6.5 μM。
-
GC36006
Esculentoside H
商陆皂苷辛
Esculentoside H (EsH) 是从多年生植物 Phytolacca esculent 的根提取物中分离和纯化的水溶性皂苷。Esculentoside H (EH) 具有抗肿瘤活性,其机制与 TNF 释放能力有关。Esculentoside H (EsH) 通过阻断 JNK1/2 和 NF-κB 信号介导的基质金属蛋白酶-9 (MMP-9) 表达抑制结肠癌细胞迁移。
-
GC35996
Epiberberine chloride
表小檗碱氯化物
An alkaloid with diverse biological activities
-
GC35855
diABZI STING agonist-1 trihydrochloride
Diamidobenzimidazole STING Agonist-1, STING Agonist (Compound 3), STING Agonist diABZI
diABZI STING agonist-1 trihydrochloride 作为一种 STING 激动剂,通过未知受体内化到细胞质中并诱导 STING 的激活和二聚化,然后是 TBK1/IRF3 磷酸化,从而导致 I 型 IFN 反应。
-
GC35854
diABZI STING agonist-1 Tautomerism
diABZI STING agonist (diABZI STING agonist-1, Compound 3, Tautomerism) is a potent non-nucleotide STING agonist and has tremendous potential to improve treatment of cancer in humans.
-
GC35853
diABZI STING agonist-1
diABZI STING agonist-1是干扰素基因刺激物(STING)途径的激动剂,其在人和小鼠中的EC50值分别为130nM 和186nM。
-
GC35724
Complement C5-IN-1
Compound C5-IN-1 (Compound 7) 是补体成分蛋白5 (C5) 的小分子抑制剂。Compound C5-IN-1 与 C5 相互作用以防止其被 C5 转化酶切割, 阻断酵母多糖诱导的 50%人全血 MAC 沉积的 IC50 值为 0.77 μM。
-
GC35703
Citicoline
胞磷胆碱; Cytidine diphosphate-choline; CDP-Choline; Cytidine 5'-diphosphocholine
An intermediate in the synthesis of phosphatidylcholine
-
GC35674
Chicanine
襄五脂素
Chicanine 是五味子中的木酚素类化合物,可抑制 LPS 诱导的 p38 MAPK,ERK 1/2 和 IκB-α 的磷酸化水平,具有抗炎活性。
-
GC35630
CDDO-EA
CDDO ethyl amide; TP319; RTA 405
CDDO-EA 是一种 NF-E2 相关因子 2 /抗氧化反应元件 (Nrf2/ARE) 激活剂。
-
GC35629
CDDO-dhTFEA
RTA dh404
CDDO-dhTFEA (RTA dh404) 是一种合成的齐墩果烷三萜化合物,有效激活 Nrf2 并抑制促炎转录因子 NF-κB。 CDDO-dhTFEA 可以恢复高血压 (MAP),增加 Nrf2 及其靶基因的表达,减弱 NF-κB 的活化和转化生长因子-β 途径,并减少慢性肾病 (CKD) 大鼠的肾小球硬化,间质纤维化和炎症。
-
GC35575
C3a (70-77) TFA
Complement 3a (70-77) (TFA)
C3a (70-77) TFA (Complement 3a (70-77) TFA) 是对应于 C3a 的 COOH 末端的八肽,表现出 C3a 的特异性和 1 至 2% 的生物活性。